PCI provides integrated end-to-end drug development, manufacturing, and packaging solutions to clients around the globe. With over 6000 employees in 30 sites across Australia, Canada, North America, the UK, and Europe, PCI brings the proven experience of more than 90 successful product launches each year and over five decades in delivering CDMO services. Leading technology and continued investment enable us to provide development to commercialization solutions throughout the product lifecycle, collaborating with our clients to improve the lives of patients globally.
Visit Company Website
